Cancer métastatique du foie is a cancer that started in another part of the body and spread to the foie. The place where the cancer started is called the primary site. The new tumors in the liver are called liver metastases. They are far more common than cancers that start in the liver itself.
A cancer that has spread to the liver keeps the name of the place where it started. For example, colon cancer that has spread to the liver is still colon cancer, and it is treated as colon cancer. This article explains what metastatic cancer in the liver means, the different words your pathology report may use for it, and how the report helps your care team plan treatment.
Why does cancer spread to the liver?
Cancer spreads to the liver more often than to almost any other organ. The liver filters a very large amount of blood. It receives blood from the heart and, through a large vein called the portal vein, all the blood leaving the stomach and intestines. Cancer cells that break away from a tumor can travel in this blood and settle in the liver.
Cancers from almost anywhere can spread to the liver. The most common starting points are:
What are the symptoms of metastatic cancer in the liver?
Metastatic cancer in the liver often causes no symptoms at first. Many liver metastases are found on a CT scan, MRI, or ultrasound done to stage a new cancer or to check on a cancer treated in the past. When symptoms do occur, they can include:
- Pain or fullness in the upper right side of the abdomen.
- Weight loss, tiredness, and a poor appetite.
- Jaunissement de la peau et des yeux, appelé jaunisse.
- Swelling of the abdomen from fluid.
- Abnormal liver blood tests. Our guide to understanding your liver panel explains these tests.
Neuroendocrine tumors that have spread to the liver can release hormones into the blood. These hormones can cause flushing, sweating, and diarrhea.
How is the diagnosis of metastatic cancer in the liver made?
The diagnosis of metastatic cancer in the liver is made when a pathologiste examines tissue from a liver tumor under the microscope. Most often, the tissue comes from a needle biopsy guided by ultrasound or CT. Our guide to understanding your liver biopsy pathology report explains how the sample is collected. Sometimes the tissue comes from surgery to remove one or more liver tumors.
The pathologist first confirms that the tumor is cancer. Next, they decide whether it started in the liver or spread there from somewhere else. Cancers from different organs often look different under the microscope. If you have had cancer before, the pathologist compares the liver tumor with your earlier cancer, sometimes by reviewing the original slides.
When the starting point is not already known, the pathologist uses special stains to narrow down where the cancer began. Your care team then combines the pathology results with scans and other tests to find the primary site. These stains are described in the next section.
Immunohistochimie
Immunohistochimie is a test that uses special stains to show which proteins the cancer cells make. In metastatic cancer in the liver, it helps show what kind of cell the cancer came from. Each organ makes its own set of proteins, and many cancers keep making them after they spread. Your report may list some of these results:
- CK7 et CK20. The pattern of these two proteins narrows the list of possible starting points. Cancers of the colon and rectum are usually CK20-positive and CK7-negative.
- CDX2 et SATB2. These point to the intestines, especially the colon and rectum.
- TTF-1 et napsine A. These point to the lung.
- GATA3 et récepteur d'oestrogène. Together, these point to the breast.
- PAX8. This points to the kidney, ovary, or uterine lining.
- NKX3.1 and PSA. These point to the prostate.
- SOX10 et Mélan-A. These point to melanoma.
- Synaptophysine, chromogranine et INSM1. These show that the cancer is a neuroendocrine tumor or neuroendocrine carcinoma.
- HepPar-1, arginase-1, and glypicane-3. These are made by liver cells. A negative result supports a cancer that spread to the liver rather than one that started there.
- Ki-67. This shows how many cancer cells are dividing. In a neuroendocrine tumor, it is used to grade the tumor from 1 to 3, where a higher grade means faster growth.
No single stain is perfect, so pathologists read the results as a pattern. Not every case needs every stain. Some cancers, such as those from the pancreas, bile ducts, and stomach, can look alike even with stains. In those cases, scans and scopes help determine where the cancer started.
What your report may call metastatic cancer in the liver
Pathologists use different words for metastatic cancer in the liver. The wording depends on the cancer type, how sure the pathologist is about where it started, and their personal style. Your report may say:
- Carcinome métastatique or adénocarcinome métastatique. Carcinoma is the most common type of cancer. Adenocarcinoma is a carcinoma that forms glands, such as cancers of the colon, pancreas, stomach, lung, and breast.
- A named cancer. When the starting point is clear, the report may name it. Examples are “metastatic colorectal adenocarcinoma,” “metastatic breast carcinoma,” or “metastatic melanoma.”
- “Consistent with,” “compatible with,” or “in keeping with.” These phrases mean the findings fit a particular starting point, such as “consistent with a colorectal primary.” This usually reflects strong confidence.
- “Favor,” “suggestive of,” or “cannot exclude.” These phrases mean the pathologist leans toward one starting point but cannot be certain from the sample alone. Your care team will use scans and other tests to decide.
- “Consistent with the patient’s known cancer.” This means the liver tumor looks the same as a cancer you had before.
- A diagnosis without the word “metastatic.” Some reports simply say “adenocarcinoma” with a comment. This happens when an adenocarcinoma could have started in the bile ducts of the liver, a cancer called cholangiocarcinome intrahépatique. The two can look the same under the microscope.
- Neuroendocrine tumor with a grade. A report may say “well-differentiated tumeur neuroendocrine, grade 2.” Although it is called a tumor, a neuroendocrine tumor that has spread to the liver is a cancer.
- "Carcinome peu différenciénous »néoplasme malin. » These terms are used when the cancer cells look very abnormal and give few clues to where they started. If no starting point is found after all tests, doctors call it cancer of unknown primary.
- "Positif pour la malignité. » This wording is common when cells were collected with a very thin needle. It means cancer cells were found.
- Lymphoma in the liver. Lymphoma is a cancer of immune cells. When it is found in the liver, the report usually says “involved by lymphoma” rather than “metastatic.” See lymphome.
If the wording in your report is not clear, your doctor can ask the pathologist what it means for you. The comment at the end of the report often explains how certain the diagnosis is.
What does metastatic cancer in the liver mean for the stage?
Cancer stage describes how far it has spread. Cancer stage is often written using the Système TNM, where M stands for spread to distant organs. Metastatic cancer in the liver is distant spread, so it is recorded as M1.
For most cancers, M1 means stage 4. A liver biopsy report usually does not assign a stage. Your oncologist assigns the overall stage using the pathology report, your scans, and the details of your primary cancer. Stage 4 does not mean the same thing for every cancer. For some cancers, including colorectal cancer and neuroendocrine tumors, liver metastases can sometimes be removed or controlled for many years.
If liver metastases were removed by surgery
When liver metastases are removed by surgery, the pathology report describes them in more detail. This most often happens with colorectal cancer and neuroendocrine tumors. Your report may include:
- Number and size of tumors. The pathologist counts the metastases in the tissue removed and measures the largest one.
- Les marges. The margin is the cut edge of the liver tissue removed. A negative margin means no cancer cells were seen at the edge. A positive margin means cancer cells reach the edge, so some cancer may remain.
- Effet du traitement. If you had chemotherapy before surgery, the pathologist estimates how much of the tumor is still living cancer. Less remaining cancer means the treatment worked well. Your report may describe this as régression tumorale or as a percentage of viable tumor.
- The rest of the liver. The pathologist also looks at the liver around the tumors. Chemotherapy can cause fat to build up in liver cells, called stéatose. It can also damage the small blood vessels of the liver, which the report may call sinusoidal injury.
Tests de biomarqueurs et de biologie moléculaire
Biomarker testing looks for changes in the cancer cells that help doctors choose treatment. In metastatic cancer in the liver, a liver biopsy is often the sample used for this testing. The tests depend on where the cancer started:
Biomarker results often come back days or weeks after the main pathology report. To learn more about specific tests, visit our Biomarqueurs .
What is the prognosis for metastatic cancer in the liver?
The prognosis for metastatic cancer in the liver depends mostly on where the cancer started. It also depends on how many liver metastases there are, whether the cancer has spread elsewhere, and how well it responds to treatment. For most cancers, spread to the liver means the cancer cannot be cured. Treatment can still shrink or control it, often for a long time.
Some situations have a better outlook:
- Colorectal cancer that can be removed. When all liver metastases from colorectal cancer can be removed, about 4 in 10 people are alive five years later. Some are cured. However, most people with colorectal liver metastases cannot have surgery, and the cancer often returns after it.
- Tumeurs neuroendocrines. These usually grow slowly. Many people live for years with liver metastases from a low-grade neuroendocrine tumor.
- Cancers with a targetable biomarker. Targeted therapy or immunotherapy can control some cancers for a long time.
Liver metastases from cancers of the pancreas and stomach usually have a poorer outlook. Your oncologist can explain what the findings mean for you.
What happens after the diagnosis of metastatic cancer in the liver?
After metastatic cancer in the liver is confirmed, a team of cancer specialists reviews the pathology report with your scans. The team often includes a medical oncologist, liver surgeon, radiologist, and radiation oncologist. The findings that matter most are where the cancer started, how much of the liver is involved, and the biomarker results.
Options your care team may consider include:
- Traitement médicamenteux. Chemotherapy, hormone therapy, targeted therapy, or immunotherapy treat cancer throughout the body. The choice depends on the primary site and biomarker results.
- Chirurgie. Removing part of the liver may be considered when there are few metastases and the cancer has not spread widely, most often for colorectal cancer or neuroendocrine tumors.
- Ablation. A needle placed in the tumor destroys it with heat or cold. This can be used for small metastases.
- Treatment through the liver’s blood supply. A doctor delivers tiny beads carrying chemotherapy or radiation directly into the arteries feeding the tumors.
- Radiothérapie. Focused radiation can target a small number of liver tumors.
- Finding the primary site. If the starting point is not known, you may need more scans, a scope test, or a mammogram.
- Supportive care. Specialists in symptom control can help with pain, tiredness, and appetite at any stage.
Questions à poser à votre médecin
- Where did my cancer start, and how certain is the pathologist?
- What does the wording in my report, such as “consistent with” or “favor,” mean in my case?
- Could this cancer have started in the liver rather than spreading there?
- Which immunohistochemistry stains were done, and what did they show?
- If the starting point is unknown, what other tests do I need?
- Is this the same cancer I had before, or a new one?
- How many liver metastases are there, and has the cancer spread anywhere else?
- Quel est le stade global de mon cancer?
- Which biomarker tests were done on my liver biopsy, and when will the results be ready?
- Could my liver metastases be removed by surgery or treated with ablation?
- If I had surgery, were the margins negative, and how much cancer was left after chemotherapy?
- What is the goal of my treatment: cure or long-term control?
- Suis-je admissible à des essais cliniques ?
Articles connexes sur MyPathologyReport.com